AICHER, THOMAS DANIEL,BOYD, STEVEN ARMEN,CHICARELLI, MARK JOSEPH,CONDROSKI, KEVIN RONALD,FELL, JAY BRADFORD,FISCHER, JOHN P.,GUNAWARDANA, INDRANI W.,HINKLIN, RONALD JAY,SINGH, AJAY,TURNER, TIMOTHY M.
申请号：
CA2699718
公开号：
CA2699718C
申请日:
2008.09.15
申请国别(地区):
CA
年份:
2014
代理人:
摘要：
Provided are compounds of Formula (I): wherein R2, R3, R13, L and D2 are asdefined in the specification, whichare useful in the treatment and/or prevention of diseases or disordersmediated by deficient levels of glucokinase activity or whichcan be treated by activating glucokinase including, but not limited to,diabetes mellitus, impaired glucose tolerance, IFG (impairedfasting glucose) and IFG (impaired fasting glycemia), as well as otherdiseases and disorders such as those discussed herein.
